Fennec Pharmaceuticals Inc.

NASDAQ:FENC

4.65 (USD) • At close October 17, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000
Omzet 21.6421.53500.1700000000000000000000
Kosten van de omzet 1.2820.08600000000000000000000-0.0550
Brutowinst 20.361.44900.170000000000000000000.0550
Brutowinstmarge 0.9410.9440100000000000000000083,5971
Onderzoek- en ontwikkelingskosten 0.0573.5314.9815.1055.6075.0081.9360.4720.2560.3570.5972.0751.4940.7082.11310.36610.91214.00312.4413.5883.5463.1341.910.939
Algemene en administratieve kosten 20.58517.72212.24212.957.4025.4015.0152.3991.6342.521.3341.545000000000000
Verkoop- en marketingkosten 12.1232.7850000000000000000000000
Verkoop-, algemene en administratieve kosten 33.30820.50712.24212.957.4025.4015.0152.3991.6342.521.3341.5451.9443.8961.2143.523.2782.8833.1823.4941.7810.9070.7390.614
Overige kosten 0.28700-0.009-0.0170.006-0.008-0.01400-0.003-0.005000002.1772.7232.341.41800.0550.052
Bedrijfskosten 33.36524.03817.22318.05513.00910.4096.9512.8711.892.8771.9313.623.4384.6042.8313.88614.1919.06318.3469.4226.7454.0412.7041.606
Bedrijfsresultaat -13.005-22.589-17.223-17.885-13.009-10.409-6.951-2.871-1.89-2.877-1.931-3.62-3.438-4.604-3.216-13.886-14.19-19.063-18.346-9.422-6.745-4.041-2.649-1.606
Bedrijfsresultaat ratio -0.601-14.7160-105.206000000000000000000-4,009,001.123-2,376,299.432
Totaal overige inkomsten en kosten netto -3.334-1.125-0.123-0.2240.2340.173-0.1420.0741.2280.6993.774-1.5688.08-3.251-0.22913.88614.19-2.021-3.539-0.1710.0790.3210.1940.008
Inkomen voor belasting -16.339-23.714-17.346-18.109-12.775-9.888-7.046-2.789-0.659-2.1761.845-5.1634.685-7.823-3.012-13.6-13.357-20.638-21.535-9.593-6.665-3.72-2.455-1.597
Inkomen voor belasting ratio -0.755-15.4490-106.524000000000000000000-3,715,126.04-2,364,003.67
Belastingkosten 01.1250.11-0.187-0.315-0.348-0.047-0.008-0.003-0.002-0.002-0.025-0.0437.8233.01213.613.357-1.535-2.29-0.855-0.5183.722.4551.597
Nettowinst -16.339-24.839-17.456-17.922-12.46-9.888-7.046-2.789-0.659-2.1761.845-5.1634.685-7.823-3.012-13.6-13.357-19.103-19.245-8.737-6.147-3.72-2.455-1.597
Nettowinstmarge -0.755-16.1820-105.424000000000000000000-3,715,126.04-2,364,003.67
WPA (Winst Per Aandeel) -0.61-0.95-0.67-0.76-0.63-0.52-0.47-0.22-0.061-0.220.19-0.630.59-1.11-0.98-4.43-4.78-16.72-20.45-15.04-19.85-19.32-20.12-2.98
Verwaterde WPA -0.61-0.95-0.67-0.76-0.63-0.52-0.47-0.22-0.061-0.220.17-0.620.58-1.11-0.98-4.43-4.78-16.72-20.45-15.04-19.85-19.32-4.04-2.98
EBITDA -13.005-22.543-17.185-17.985-13.009-10.576-6.817-2.959-3.118-3.576-1.932-3.6-3.395-1.353-2.601-13.722-13.998-14.614-14.93-6.903-5.218-4.239-2.788-1.562
EBITDA ratio -0.601-14.6860-105.794000000000000000000-4,219,281.181-2,311,624.326